[1] |
Jemal A, Siegel R, Xu J, et al. Cancer statistics,2010[J]. CA Cancer J Clin,2010,60(5):277-300.
|
[2] |
王启俊, 祝伟星, 邢秀梅. 北京城区女性乳腺癌发病死亡和生存情况20年监测分析[J]. 中华肿瘤杂志, 2006,28(3):208-210.
|
[3] |
Rabinovitch R, Kavanagh B. Double Helix of breast cancer therapy:intertwining the Halsted and Fisher hypotheses[J]. J Clin Oncol,2009,27(15):2422-2423.
|
[4] |
Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers[J]. J Clin Oncol, 1994, 12(10):2229-2234.
|
[5] |
Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials[J]. Lancet, 2005, 366(9503):2087-2106.
|
[6] |
Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer[J]. N Engl J Med,2004,351(10):971-977.
|
[7] |
Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer[J]. N Engl J Med,2002,347(16):1227-1232.
|
[8] |
Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy,lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer[J]. N Engl J Med, 2002,347(16):1233-1241.
|
[9] |
Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer[J]. N Engl J Med,2004,351(10):963-970.
|
[10] |
Rastogi P, Anderson SJ, Bear HD, et al. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27[J]. J Clin Oncol,2008,26(5):778-785.
|
[11] |
Mathew J, Asgeirsson KS, Cheung KL, et al. Neoadjuvant chemotherapy for locally advanced breast cancer: a review of the literature and future directions[J]. Eur J Surg Oncol,2009,35(2):113-122.
|
[12] |
Perloff M, Lesnick GJ, Korzun A, et al. Combination chemotherapy with mastectomy or radiotherapy for stage Ⅲbreast carcinoma: a Cancer and Leukemia Group B study[J]. J Clin Oncol,1988,6(2):261-269.
|
[13] |
Tewari M, Krishnamurthy A, Shukla HS. Breast conservation in locally advanced breast cancer in developing countries:wise or waste[J]. Surg Oncol,2009,18(1):3-13.
|
[14] |
沈松杰, 孙强. 复发转移性乳腺癌手术治疗进展[J]. 中华普通外科杂志,2011,26(8):706-708.
|
[15] |
Buchanan CL, Dorn PL, Fey J, et al. Locoregional recurrence after mastectomy: incidence and outcomes[J]. J Am Coll Surg,2006,203(4):469-474.
|
[16] |
Chagpar A, Meric-Bernstam F, Hunt KK, et al. Chest wall recurrence after mastectomy does not always portend a dismal outcome[J]. Ann Surg Oncol,2003,10(6):628-634.
|
[17] |
Pagani O, Senkus E, Wood W, et al. International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured? [J]. J Natl Cancer Inst,2010,102(7):456-463.
|
[18] |
Khan SA,Stewart AK,Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? [J]. Surgery,2002,132(4):620-626.
|
[19] |
Gnerlich J, Jeffe DB, Deshpande AD, et al. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data[J]. Ann Surg Oncol,2007,14(8):2187-2194.
|
[20] |
Soran A,Ozbas S,Kelsey SF,et al. Randomized trial comparing locoregional resection of primary tumor with no surgery in stage Ⅳbreast cancer at the presentation (Protocol MF07-01): a study of Turkish Federation of the National Societies for Breast Diseases[J]. Breast J,2009,15(4):399-403.
|
[21] |
Soran A. The impact of primary surgery on tumor progression in metastatic breast cancer (BC) patients:Protocol MF07-01 randomized study interim analysis[C]/ / 2010 Breast Cancer Symposium. Washington DC:American Society of Clinical Oncology,2010:93.
|